Tara Bancroft
Stock Analyst at TD Cowen
(1.87)
# 3,241
Out of 5,148 analysts
11
Total ratings
44.44%
Success rate
5.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics | Maintains: Buy | $90 → $100 | $94.24 | +6.11% | 2 | Feb 26, 2026 | |
| DAWN Day One Biopharmaceuticals | Initiates: Buy | $34 | $10.37 | +227.87% | 1 | Jan 13, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $10.98 | +82.15% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $76.30 | +4.85% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $29.40 | +70.07% | 1 | Oct 29, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.55 | +545.16% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $5.73 | - | 1 | Aug 31, 2022 |
Protagonist Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $90 → $100
Current: $94.24
Upside: +6.11%
Day One Biopharmaceuticals
Jan 13, 2026
Initiates: Buy
Price Target: $34
Current: $10.37
Upside: +227.87%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $10.98
Upside: +82.15%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $76.30
Upside: +4.85%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $29.40
Upside: +70.07%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.55
Upside: +545.16%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $5.73
Upside: -